Schedule Eval

News & Events

News

Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer

Read the Press Release

UroViu Corporation Appoints Ali Amiri as New President and Chief Operating Officer

Read the Press Release

UroViu Launches Uro-GHD, a New High-Definition Sterile Single-Use Cystoscope

Read the Press Release

Events

Come visit us at the following tradeshows to learn more about the UroViu platform

Book an evaluation to learn more ahead of meeting us in person. We look forward to seeing you there! 

No event found!
Load More
View Past Events

Simplify the scope of patient care

Linkedin Twitter Facebook

Schedule a single-use trial evaluation

Book Now

The UroViu 4500 Handle, Uro-V Diagnostic Cannula, Uro-G Fully Deflectable Cannula, Uro-N Injection Cannula and Hystero-V Diagnostic Cannula are FDA 510(k) cleared.

 UroViu’s endoscope products are protected by one or more U.S. patents: uroviu.com/patents/

Additional U.S. and foreign patent applications are pending. All other trademarks are the property of their respective holders. LBL-1 Rev 06

©2021-2023 UroViu Corporation